Germany Radiation Oncology Market Size & Outlook
Germany radiation oncology market, 2017-2028 (US$M)
Related Markets
Germany radiation oncology market highlights
- The Germany radiation oncology market generated a revenue of USD 413.0 million in 2020 and is expected to reach USD 713.0 million by 2028.
- The Germany market is expected to grow at a CAGR of 7.1% from 2021 to 2028.
- In terms of segment, external beam radiationtherapy was the largest revenue generating type in 2020.
- Internal Beam Radiation Therapy is the most lucrative type segment registering the fastest growth during the forecast period.
Radiation oncology market data book summary
| Market revenue in 2020 | USD 413.0 million |
| Market revenue in 2028 | USD 713.0 million |
| Growth rate | 7.1% (CAGR from 2020 to 2028) |
| Largest segment | External beam radiationtherapy |
| Fastest growing segment | Internal Beam Radiation Therapy |
| Historical data | 2017 - 2019 |
| Base year | 2020 |
| Forecast period | 2021 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | External Beam RadiationTherapy, Internal Beam Radiation Therapy |
| Key market players worldwide | Siemens Healthineers AG ADR, Elekta AB ADR, BD, Accuray Inc, IBA RadioPharma Solutions, IsoRay, MeVis Medical Solutions AG, Nordion, Ntp Radioisotopes, Curium Pharma, ViewRay |
Other key industry trends
- In terms of revenue, Germany accounted for 5.4% of the global radiation oncology market in 2020.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
- In Europe, Germany radiation oncology market is projected to lead the regional market in terms of revenue in 2028.
- UK is the fastest growing regional market in Europe and is projected to reach USD 500.6 million by 2028.
External beam radiationtherapy was the largest segment with a revenue share of 68.57% in 2020. Horizon Databook has segmented the Germany radiation oncology market based on external beam radiationtherapy, internal beam radiation therapy covering the revenue growth of each sub-segment from 2017 to 2028.
Rising incidence of cancer in this country is one of the major drivers anticipated to accelerate the demand for radiation oncology treatment. Lung cancer is the most common cause of death in this country.
According to Globocan, in 2018, it was reported that 50,560 individuals died of lung cancer. Furthermore, around 1,943,860 cases of cancer were reported in 2018 of which 71,888 were breast cancer and 62,641 were prostate cancer cases.
In addition, presence of major market players such as IBA and rising awareness programs are expected to fuel the radiation oncology market growth. The German Society for Radiation Oncology e.V. (DEGRO) initiative was launched with an aim to treat all patients with tumor with radiation.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Radiation Oncology Market Scope
Radiation Oncology Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Germany radiation oncology market size, by type, 2017-2028 (US$M)
Germany Radiation Oncology Market Outlook Share, 2020 & 2028 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
